Lucid Diagnostics Inc.
General ticker "LUCD" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $116.8M (TTM average)
Lucid Diagnostics Inc. does not follow the US Stock Market performance with the rate: -23.2%.
Estimated limits based on current volatility of 7.9%: low 0.51$, high 0.59$
Factors to consider:
- Total employees count: 82 (+13.9%) as of 2025
- Company does not operate outside North America (retrieved using AI)
- Top business risk factors: Failure to achieve profitability, Need additional capital, Parent company obligations, Limited operating history, Dependence on licensing agreements
- Current price 33.9% below estimated low
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [0.72$, 1.71$]
- 2026-12-31 to 2027-12-31 estimated range: [0.69$, 1.64$]
Financial Metrics affecting the LUCD estimates:
- Positive: with PPE of -2.4 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: negative Operating cash flow
- Positive: -51.61 < Industry operating profit margin (median), % of -29.60
- Positive: Industry inventory ratio change (median), % of 0.70 <= 1.15
- Positive: Interest expense per share per price, % of 0.02 <= 0.07
- Positive: -1.23 < Investing cash flow per share per price, % of -0.18
- Negative: negative Net income
Short-term LUCD quotes
Long-term LUCD plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $2.43MM | $4.35MM | $4.71MM |
| Operating Expenses | $50.91MM | $50.40MM | $54.35MM |
| Operating Income | $-48.48MM | $-46.05MM | $-49.64MM |
| Non-Operating Income | $-4.18MM | $0.52MM | $-8.37MM |
| Interest Expense | $0.42MM | $0.03MM | $0.02MM |
| R&D Expense | $7.25MM | $5.99MM | $5.68MM |
| Income(Loss) | $-52.67MM | $-45.53MM | $-58.01MM |
| Net Income(Loss)* | $-52.67MM | $-45.53MM | $-58.01MM |
| Stockholders Equity | $-2.31MM | $5.39MM | $10.94MM |
| Inventory | $0.28MM | $0.34MM | $0.35MM |
| Assets | $27.27MM | $30.71MM | $40.45MM |
| Operating Cash Flow | $-32.82MM | $-44.14MM | $-46.48MM |
| Capital expenditure | $0.22MM | $0.65MM | $0.20MM |
| Investing Cash Flow | $-0.22MM | $-0.65MM | $-0.20MM |
| Financing Cash Flow | $29.46MM | $48.25MM | $59.03MM |
| Earnings Per Share** | $-1.26 | $-0.90 | $-0.57 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.